Roth Capital Assumes bluebird bio (BLUE) at Buy

September 22, 2016 8:15 AM EDT
Get Alerts BLUE Hot Sheet
Price: $65.00 -2.62%

Rating Summary:
    15 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade BLUE Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Roth Capital assumed coverage on bluebird bio (NASDAQ: BLUE) with a Buy rating and a price target of $87.00.

For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.

Shares of bluebird bio closed at $73.81 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Roth Capital

Add Your Comment